Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer

Breast cancer statistics, 2011

(2011) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Balance between SIRT1 and DBC1 expression is lost in breast cancer

(2010) Ji-Youn Sung et al.   CANCER SCIENCE

Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma

(2010) Ho Lee et al.   HUMAN PATHOLOGY

T1N0 Triple Negative Breast Cancer: Risk of Recurrence and Adjuvant Chemotherapy

(2009) Henry G. Kaplan et al.   Breast Journal

Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer

(2009) Carey K. Anders et al.   Clinical Breast Cancer

Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma

(2009) E. J. Cha et al.   CLINICAL CANCER RESEARCH

Expression and prognostic significance of SIRT1 in ovarian epithelial tumours

(2009) Kyu Yun Jang et al.   PATHOLOGY

SIRT1 Expression is Associated With Poor Prognosis of Diffuse Large B-Cell Lymphoma

(2008) Kyu Yun Jang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Impact of Triple Negative Phenotype on Breast Cancer Prognosis

(2008) Henry G. Kaplan et al.   Breast Journal

Overexpression of SIRT1 Protects Pancreatic  -Cells Against Cytokine Toxicity by Suppressing the Nuclear Factor- B Signaling Pathway

(2008) J.-H. Lee et al.   DIABETES

Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer

(2008) Brittney Jung-Hynes et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Basal-Like Breast Cancer: A Critical Review

(2008) Emad A. Rakha et al.   JOURNAL OF CLINICAL ONCOLOGY

The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth

(2008) Ron Firestein et al.   PLoS One